5-HT/CGRP pathway and Sumatriptan role in Covid-19

HM Al-Kuraishy, AI Al-Gareeb, A Alexiou… - Biotechnology and …, 2022 - Taylor & Francis
ABSTRACT Coronavirus disease 2019 (Covid-19) is a pandemic caused by severe acute
respiratory syndrome coronavirus type 2 (SARS-CoV-2). In Covid-19, there is uncontrolled …

The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19

P Jiang, J Ye, M Jia, X Li, S Wei, N Li - Frontiers in Pharmacology, 2022 - frontiersin.org
Background: Similar pathogenesis makes Corona Virus Disease 2019 (COVID-19)
associated with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and gouty arthritis …

Discovery of the key active compounds in Citri Reticulatae Pericarpium (Citrus reticulata “Chachi”) and their therapeutic potential for the treatment of COVID-19 based …

F Wang, L Chen, H Chen, Z Yan, Y Liu - Frontiers in Pharmacology, 2022 - frontiersin.org
Edible herbal medicines contain macro-and micronutrients and active metabolites that can
take part in biochemical processes to help achieve or maintain a state of well-being. Citri …

A Systematic Review of the Role of Purinergic Signalling Pathway in the Treatment of COVID-19

VG Korb, IC Schultz, LR Beckenkamp… - International Journal of …, 2023 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has become a global health concern. Three years …

Exploring the role of Xingren on COVID‐19 based on network pharmacology and molecular docking

M Wang, B Yu, J Wang, Y Wang… - Journal of Food …, 2022 - Wiley Online Library
Since the outbreak of novel Coronavirus Pneumonia 2019 (COVID‐19), the role of Almonds
(Xingren) in the protection and treatment of COVID‐19 is not clear. Network pharmacology …

Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19?

LHA Costa, BM Santos, LGS Branco - European journal of pharmacology, 2020 - Elsevier
The absence of a specific treatment for SARS-CoV-2 infection led to an intense global effort
in order to find new therapeutic interventions and improve patient outcomes. One important …

Anti–coronavirus disease 2019 (COVID‐19) targets and mechanisms of puerarin

X Qin, C Huang, K Wu, Y Li, X Liang… - Journal of cellular and …, 2021 - Wiley Online Library
The present study aimed to uncover the pharmacological function and underlying
mechanism of puerarin as a potential treatment for COVID‐19, using an in silico …

Exploring the potential pharmacological mechanism of hesperidin and glucosyl hesperidin against COVID-19 based on bioinformatics analyses and antiviral assays

Y Huang, W Zhou, J Sun, G Ou… - The American journal of …, 2022 - World Scientific
The development of anti-COVID-19 drugs has become the top priority since the outbreak of
the epidemic, and Traditional Chinese medicine plays an important role in reducing …

Does serotonin deficiency lead to anosmia, ageusia, dysfunctional chemesthesis and increased severity of illness in COVID-19?

A Sen - Medical Hypotheses, 2021 - Elsevier
Different mechanisms forwarded to understand anosmia and ageusia in coronavirus
patients are not adequate to explain reversible anosmia and ageusia, which are resolved …

[HTML][HTML] Assessing the therapeutic potential of agomelatine, ramelteon, and melatonin against SARS-CoV-2

PK Yadalam, TM Balaji, S Varadarajan… - Saudi Journal of …, 2022 - Elsevier
Abstract Background The SARS-Cov-2 (severe acute respiratory syndrome coronavirus 2)
infection affecting human populations worldwide is now a very concerning issue considering …